Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Fluvoxamine, a specific 5-hydroxytryptamine uptake inhibitor.

V Claassen, J E Davies, G Hertting

    British Journal of Pharmacology
    |August 1, 1977
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Location of side branch access critically affects results in bifurcation stenting: Insights from bench modeling and computational flow simulation.

    International journal of cardiology·2013
    Same author

    Recent developments in renal denervation.

    Minerva cardioangiologica·2013
    Same author

    Importance of knowing stent design threshold diameters and post-dilatation capacities to optimise stent selection and prevent stent overexpansion/incomplete apposition during PCI.

    International journal of cardiology·2012
    Same author

    Stent flexibility versus concertina effect: mechanism of an unpleasant trade-off in stent design and its implications for stent selection in the cath-lab.

    International journal of cardiology·2012
    Same author

    Structure of a 12-Vertex Arachno Carborane, -((5)-C(5)H(5))Co-((5)-C(5)H(4))(+)---(CH(3))(4)C(4)B(8)H(8)(6-) and C(2)B(10)H(12)(4-). Mechanisms of Carborane Fluxional Behavior and Metallocarborane Formation from the (CH(3))(4)C(4)B(8)H(8)(2-) Ion.

    Journal of the American Chemical Society·2012
    Same author

    Developing and paying for medicines for orphan indications in oncology: utilitarian regulation vs equitable care?

    British journal of cancer·2012

    Fluvoxamine shows potential as an antidepressant by selectively inhibiting serotonin (5-HT) uptake, impacting brain chemistry and behavior. It minimally affects noradrenaline, distinguishing it from other antidepressants.

    Area of Science:

    • Pharmacology
    • Neuroscience
    • Medicinal Chemistry

    Background:

    • Fluvoxamine is investigated for its antidepressant potential.
    • Its mechanism of action is primarily linked to serotonin (5-HT) pathways.

    Purpose of the Study:

    • To characterize fluvoxamine's pharmacological profile.
    • To elucidate its selective inhibition of 5-HT uptake and compare it with tricyclic antidepressants.

    Main Methods:

    • In vitro and in vivo experiments were conducted.
    • Studies involved blood platelets, brain synaptosomes, and animal models (mice, rats).
    • Assays measured 5-HT and noradrenaline uptake inhibition, 5-HT turnover, and behavioral effects.

    Main Results:

    Related Experiment Videos

  • Fluvoxamine selectively inhibits 5-HT uptake in platelets and brain synaptosomes, preventing 5-HT depletion.
  • It decreases central 5-HT turnover and potentiates 5-hydroxytryptophan (5-HTP) effects.
  • Unlike tricyclic antidepressants, fluvoxamine shows minimal to no inhibition of noradrenaline uptake.

    • Conclusions:

    • Fluvoxamine acts as a potent and selective 5-HT uptake inhibitor.
    • Its distinct pharmacological profile suggests a specific mechanism for antidepressant activity.
    • Fluvoxamine's limited impact on noradrenaline differentiates it from traditional antidepressants.